Tele-dermatology Non-presential (TeleDermaSA) (TeleDermaSA)

Evaluation of the Implementation of Tele-dermatology, in Its Modality of Non-presential Inter-consultation, in the Province of Salamanca.

The purpose of the study is to evaluate the implementation of the Non-Face-to-Face Interconsultation of dermatology since it began to be used in August 2020 until August 2022 in the province of Salamanca (Spain)

Study Overview

• Status: Completed
• Conditions: Primary Care; Teledermatology
• Intervention / Treatment: Other: data collection protocol in clinical history

Detailed Description

Design: cross-sectional descriptive study. Subjects: The unit of analysis will be the NPIs performed in dermatology since its implementation in August 2020 until the present time in the health area of Salamanca. To analyze the face-to-face consultations to analyze the differences. A random sample of 500 PNCIs and 500 face-to-face consultations will be extracted.

Measurements: To analyze the ICNP and face-to-face IC to dermatology registered in the computerized clinical history made in PC from Medora and registered in Jimena. To record the number of consultations, type of pathology referred, dermatology response time, discharges after assessment, face-to-face consultations required, delay time, treatment required, follow-up required or not, diagnostic coincidence, quality of the photographic image sent.

A differentiated analysis will be made according to the use or not of the dermatoscope, type of center (urban, semi-urban and rural), gender of the patients and age groups.

• Study Type: Observational
• Enrollment (Actual): 1000

Contacts and Locations

• Study Contact: Name: Elena Sanchez martín, MD; Phone Number: +34615075944; Email: elengota@gmail.com
• Study Contact Backup: Name: LUIS G Garcia Ortiz, PhD; Phone Number: +34635542886; Email: lgarciao@usal.es

Study Locations

• Spain
  • Salamanca, Spain, 37003
    • Centro de Salud La Alamedilla

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 80 years (Adult, Older Adult)
• Accepts Healthy Volunteers: N/A

• Sampling Method: Probability Sample

Study Population

The unit of analysis will be the PNCIs performed in dermatology from Primary Care, registered in Medora software, with its corresponding photographic file, and its response in Jimena software of the dermatology service, from June 2021 to June 2022, one year. A random sample stratified by type of center (urban, semi-urban and rural) will be extracted.

A control group of face-to-face consultations will be used, in a similar number (500) obtained randomly, and also stratified by type of center, which will be used to compare the information from the NCIs.

Description

Inclusion Criteria:

• The unit of analysis will be the PNCIs performed in dermatology from Primary Care, registered in Medora software, with its corresponding photographic file, and its response in Jimena software of the dermatology service, from June 2021 to June 2022, one year.

Exclusion Criteria:

-

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Patients with non-face-to-face consultation; A sample of 500 patients who have undergone non-face-to-face consultation with dermatology	Other: data collection protocol in clinical history; collection of data from the clinical history according to the established protocol
Patients with face-to-face consultation; A sample of 500 patients who have undergone face-to-face consultation with dermatology	Other: data collection protocol in clinical history; collection of data from the clinical history according to the established protocol

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Derivation rates per 10,000 h.	number of patients referred to the dermatology office	1 year

Collaborators and Investigators

• Sponsor: Fundacion para la Investigacion y Formacion en Ciencias de la Salud
• Investigators: Study Director: Luis G Garcia Ortiz, PhD, FUNDACION INFOSALUD

Study record dates

Study Major Dates

• Study Start (Actual): November 1, 2022
• Primary Completion (Actual): June 1, 2023
• Study Completion (Actual): July 1, 2023

Study Registration Dates

• First Submitted: November 13, 2022
• First Submitted That Met QC Criteria: November 21, 2022
• First Posted (Actual): November 22, 2022

Study Record Updates

• Last Update Posted (Actual): July 20, 2023
• Last Update Submitted That Met QC Criteria: July 19, 2023
• Last Verified: July 1, 2023

More Information

Terms related to this study

• Other Study ID Numbers: 116

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No